Cargando…

Prostate health index is useful for prostate cancer detecting in Chinese people

BACKGROUND: Prostate cancer (PCa) incidence was increased substantially in the last two decades in China. We evaluated the performance of prostate health index (PHI) in predicting the presence of PCa in Chinese people. METHODS: A total of 108 consecutive patients were recruited to develop a PHI-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuhua, Gu, Xiaolei, Wang, Yu, Hou, Jianquan, Qi, Xiaofei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798185/ https://www.ncbi.nlm.nih.gov/pubmed/35116822 http://dx.doi.org/10.21037/tcr.2019.05.08

Ejemplares similares

A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk
por: Qi, Xiaofei, et al.
Publicado: (2017)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
por: Geng, Xinyu, et al.
Publicado: (2020)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy
por: Zhang, Xuefeng, et al.
Publicado: (2017)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

USE OF THE PROSTATE HEALTH INDEX FOR DETECTION OF PROSTATE CANCER: RESULTS FROM A LARGE ACADEMIC PRACTICE
por: Tosoian, Jeffrey J., et al.
Publicado: (2017)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
por: Zhou, Yunfen, et al.
Publicado: (2020)

Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey
por: Lin, Yuxin, et al.
Publicado: (2021)

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
por: Zhou, Chenchao, et al.
Publicado: (2017)

The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer
por: Fan, Yu-Hua, et al.
Publicado: (2021)

Prognostic values of the core components of the mammalian circadian clock in prostate cancer
por: Yue, Wenchang, et al.
Publicado: (2021)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Assessment on clinical value of prostate health index in the diagnosis of prostate cancer
por: Zhang, Guangying, et al.
Publicado: (2019)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

The Prostate Health Index and multi-parametric MRI improve diagnostic accuracy of detecting prostate cancer in Asian populations
por: Ye, Changhee, et al.
Publicado: (2022)

Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium
por: Chen, Rui, et al.
Publicado: (2015)

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022)

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China
por: Huang, Da, et al.
Publicado: (2020)

MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
por: He, Dong, et al.
Publicado: (2021)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
por: Chiu, Peter Ka-Fung, et al.
Publicado: (2016)

Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy
por: Peng, Chao, et al.
Publicado: (2019)

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men
por: Hu, Meng-Bo, et al.
Publicado: (2015)

The influence of prostate volume on cancer detection in the Chinese population
por: Wu, Yi-Shuo, et al.
Publicado: (2014)

Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study
por: Wu, Bo, et al.
Publicado: (2023)

Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer
por: Hsieh, Po-Fan, et al.
Publicado: (2021)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population
por: Wei, Han-Min, et al.
Publicado: (2015)

Malakoplakia of the Prostate as a Mimicker of Prostate Cancer on Prostate Health Index and Magnetic Resonance Imaging–Fusion Prostate Biopsy: A Case Report
por: Heah, Nathaniel H., et al.
Publicado: (2017)

Integrative molecular characterization of Chinese prostate cancer specimens
por: Lv, Shi-Dong, et al.
Publicado: (2019)

Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
por: Ye, Lie-Fu, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods
por: Pan, Yongsheng, et al.
Publicado: (2017)

Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study
por: Kim, Jae Yoon, et al.
Publicado: (2021)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cgv7gubphe8uos7e0aokdr4q4d